Stay updated on METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis
Sign up to get notified when there's something new on the METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis page.

Latest updates to the METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdds a new publication entry to the Publications section: 'Complete response of metastatic microsatellite-stable BRAF V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockade' (Oncoimmunology, 2024), and updates the revision history to v3.5.3 (removing v3.5.2).SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no visible changes to trial details or page functionality.SummaryDifference0.0%

- Check82 days agoChange DetectedAdded 'Results Posted' with related results dates and notes. Expanded content to include primary and secondary outcome measures (including PFS, safety, ORR, DOR, QoL) and linked study documents (Study Protocol and SAP).SummaryDifference3%

- Check89 days agoChange DetectedA new Revision: v3.4.2 was added, and the notice about lapse in government funding and the previous Revision: v3.4.1 were removed. These are administrative site-notice updates and do not affect the trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis
Enter your email address, and we'll notify you when there's something new on the METIMMOX Clinical Trial: OXaliplatin in Colorectal METastasis page.